These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39058929)

  • 1. Summaries of safety labeling changes approved by FDA-boxed warnings highlights, April-June 2024.
    Am J Health Syst Pharm; 2024 Aug; 81(17):e455-e456. PubMed ID: 39058929
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights April-June 2015.
    Am J Health Syst Pharm; 2015 Sep; 72(17):1430. PubMed ID: 26294231
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2019.
    Am J Health Syst Pharm; 2019 Jun; 76(13):e8-e9. PubMed ID: 31361888
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2017.
    Office of Health and Constituent Affairs, U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2017 Jun; 74(11):e292-e294. PubMed ID: 28546306
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights July-September 2015.
    Am J Health Syst Pharm; 2015 Dec; 72(23):e60-8. PubMed ID: 26581940
    [No Abstract]   [Full Text] [Related]  

  • 6. Summaries of safety labeling changes approved by FDA-boxed warnings highlights, January-March 2024.
    Am J Health Syst Pharm; 2024 Jun; 81(13):e330-e334. PubMed ID: 38801728
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries of Safety Labeling Changes Approved By FDA--Boxed Warnings Highlights July--September 2015.
    Am J Health Syst Pharm; 2015 Dec; 72(23):2008. PubMed ID: 26581924
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights October-December 2015.
    Office of Health & Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2016 Mar; 73(5):267. PubMed ID: 26896495
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, October-December 2019.
    Am J Health Syst Pharm; 2020 Apr; 77(8):e6-e8. PubMed ID: 32236460
    [No Abstract]   [Full Text] [Related]  

  • 11. Summaries of safety labeling changes approved by FDA-Boxed Warnings Highlights October-December 2014.
    Rubio T
    Am J Health Syst Pharm; 2015 Mar; 72(5):343. PubMed ID: 25694404
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries of safety labeling changes approved by FDA-boxed warnings highlights, April-June 2023.
    Am J Health Syst Pharm; 2023 Sep; 80(19):1297. PubMed ID: 37624625
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, April-June 2018.
    Office of Health and Constituent Affairs, U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2018 Sep; 75(17):e642-e653. PubMed ID: 30139737
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, April-June 2022.
    Am J Health Syst Pharm; 2022 Aug; 79(17):1404. PubMed ID: 35904363
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights January-March 2015.
    Rubio T
    Am J Health Syst Pharm; 2015 Jun; 72(11):900, 902, 904. PubMed ID: 25987678
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):739-40. PubMed ID: 27208054
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Yeh JS; Sarpatwari A; Kesselheim AS
    Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
    Garg V; Raisch DW; McKoy JM; Trifilio SM; Holbrook J; Edwards BJ; Belknap SM; Samaras AT; Nardone B; West DP
    Expert Opin Drug Saf; 2013 May; 12(3):299-307. PubMed ID: 23480866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.
    Am J Health Syst Pharm; 2023 Mar; 80(6):e74-e75. PubMed ID: 36801981
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.
    Am J Health Syst Pharm; 2023 Mar; 80(6):330. PubMed ID: 36806497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.